Research group discovers a new immune system regulator

Finnish research group discovers a new immune system regulator
Test tubes. Credit: Hanna Oksanen, University of Turku

Academy Professor Riitta Lahesmaa's research group at Turku and Åbo Akademi University, Finland, has discovered a new regulator of the immune system, a key factor that controls development of regulatory T cells. The discovery provides the basis for new strategies for the treatment of both cancer and immune-mediated diseases.

Regulatory T cells are critical controllers of the immune response. The majority of T cells boost the immune response, enhancing the ability to destroy , viruses and bacteria. In contrast, regulatory T cells can sometimes suppress the immune system's ability to attack cancer cells, allowing cancer to grow and spread. In these instances, inhibiting or braking the regulatory T cell activity would be beneficial.

"We discovered that a protein called Hypermethylated In Cancer 1, or HIC1, serves as the key regulator of regulatory T cells controlling the expression of a large set of genes contributing to T cell function," says Academy Professor Riitta Lahesmaa. "In addition, with genome-wide methods we show that HIC1 binds to sites in the nucleus that often contain genetic variations associated with immune-mediated diseases. This gives us completely new insights into molecular mechanisms that regulate T cell function and in general."


Explore further

Scientists find molecular link between Vitamin A derivative and mouse intestinal health

More information: Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells, DOI: 10.1016/j.celrep.2018.01.070 , http://www.cell.com/cell-reports/fulltext/S2211-1247%2818%2930119-0
Citation: Research group discovers a new immune system regulator (2018, February 23) retrieved 19 August 2019 from https://medicalxpress.com/news/2018-02-group-immune.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more